Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - tiotropium bromide monohydrate, quantity: 3.1235 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride - copd: spiriva respimat is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). spiriva respimat is indicated for the prevention of copd exacerbations.,asthma: spiriva respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - tiotropium bromide monohydrate, quantity: 3.1235 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride - copd: spiriva respimat is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). spiriva respimat is indicated for the prevention of copd exacerbations.,asthma: spiriva respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - tiotropium bromide as monohydrate - solution for inhalation - tiotropium bromide as monohydrate 2.5 mcg - tiotropium bromide - maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).copd:tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).asthma:spiriva respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) ltd - tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose - solution for inhalation - 2.5 mcg/dose - active: tiotropium bromide monohydrate 3.125ug equivalent to tiotropium 2.5 µg/dose excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiriva respimat is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - tiotropium bromide - solution for inhalation - 2.5 base micrograms - anticholinergics

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - tiotropium - inhalation solution - 2.5 microgram(s) - anticholinergics; tiotropium bromide

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - tiotropium - solution for inhalation - 2.5 microgram(s) - anticholinergics; tiotropium bromide

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - tiotropium -

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - tiotropium bromide monohydrate 0.003124mg eqv. tiotropium - solution - 0.0025mg/actuation - tiotropium bromide monohydrate 0.003124mg eqv. tiotropium 0.0025mg/actuation

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - tiotropium bromide monohydrate eqv tiotropium - solution - tiotropium bromide monohydrate eqv tiotropium 0.0025 mg/actuation